
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.09%
+0.06%
+1.28%
+105.41%
-3.92%
Most Trending
-0.09%
+0.06%
+1.28%
+105.41%
-3.92%
14 Nov 2025$CDTX Cidara Therapeutics explodes to new highs as reports surface of Merck nearing a multibillion-dollar acquisition. With volume surging far above average and RSI deep in overbought territory, momentum traders are watching this biotech rocket lead breakout list.
$ORI Old Republic edges into fresh-high territory following a bullish analyst upgrade that reinforces confidence in earnings resilience. Volume isn’t overwhelming, but the steady trend and renewed institutional optimism are enough to push ORI into new-high territory.
$MFG Mizuho Financial continues its slow grind higher, supported by renewed fintech, acquisition, and banking-sector interest. The stock breaks through its yearly ceiling even on lighter volume, reflecting gradual but persistent buying pressure.
$RVMD Revolution Medicines hits a perfect 52-week high print as enthusiasm builds around explosive growth forecasts for KRAS-targeting therapies. Strong RSI and persistent buying reinforce the position as a standout biotech momentum name today.
$IMNM Immunome taps new highs after multiple analyst initiations and bullish sentiment from major coverage firms. With improving volume relative to trend and a clean uptrend structure, IMNM continues to attract attention from growth-focused traders.
$SBS SBS extends its uptrend as investors react to progress in the Serra Pelada mining project. Today breakout reflects growing confidence in the operational developments and upside potential within the resource sector.
$OWLT Owlet prints a fresh high after delivering massive earnings and revenue beats, alongside higher full-year guidance. With strong RSI and rising interest from retail traders, OWLT breakout is fueled by fundamental upside and renewed growth conviction.
$CELC Celcuity pushes into new highs after five consecutive days of gains. The consistent buying streak signals strong accumulation, backed by solid volume and a firm uptrend that has traders eyeing follow-through momentum.
$APGE Apogee Therapeutics extends its breakout after multiple bullish analyst initiations and upbeat price-target outlooks. With strong volume support and an energetic uptrend, APGE continues to be one of the cleaner technical breakouts in the biotech space.
Yesterday at 09:45
Yesterday at 08:27
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.